Jorge Monge

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Acute Lymphoblastic Leukemia

Multiple Myeloma

Top Venues

Blood cancer journal

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina D Schinke, Anita D Souza, Meera Mohan
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood cancer journal 14 (1) (2024)
Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina D Schinke, Anita D Souza, Meera Mohan
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood cancer journal 14 (1) (2024)
Mateo Mejía Saldarriaga, Darren Pan, Caitlin Unkenholz, Tarek H Mouhieddine, Juan Esteban Velez-Hernandez, Katherine Engles, Joshua Alexander Fein, Jorge Monge, Cara A Rosenbaum, Roger Pearse, David S Jayabalan, Christian A Gordillo, Hei Ton Chan, Samuel Yamshon, Santiago Thibaud, Markus Y Mapara, Giorgio Ga Inghirami, Suzanne Lentzsch, Ran Reshef, Adriana Rossi, Samir Parekh, Sundar Jagannath, Shambavi Richard, Ruben Niesvizky, Mark Bustoros
Absolute Lymphocyte Count after BCMA CAR-T Therapy is a Predictor of Response and Outcomes in Relapsed Multiple Myeloma. Blood advances (2024)
Mateo Mejía Saldarriaga, Darren Pan, Caitlin Unkenholz, Tarek H Mouhieddine, Juan Esteban Velez-Hernandez, Katherine Engles, Joshua Alexander Fein, Jorge Monge, Cara Rosenbaum, Roger Pearse, David Jayabalan, Christian Gordillo, Hei Ton Chan, Samuel Yamshon, Santiago Thibaud, Markus Mapara, Giorgio Ga Inghirami, Suzanne Lentzsch, Ran Reshef, Adriana Rossi, Samir Parekh, Sundar Jagannath, Shambavi Richard, Ruben Niesvizky, Mark Bustoros
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma. Blood advances 8 (15) (2024)
Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits Van Rhee, Anita D'Souza, Aniko Szabo, Carolina D Schinke, Rajshekhar Chakraborty
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood cancer journal 14 (1) (2024)
Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina D Schinke, Anita D Souza, Meera Mohan
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood cancer journal 14 (1) (2024)
Mateo Mejía Saldarriaga, Darren Pan, Caitlin Unkenholz, Tarek H Mouhieddine, Juan Esteban Velez-Hernandez, Katherine Engles, Joshua Alexander Fein, Jorge Monge, Cara Rosenbaum, Roger Pearse, David Jayabalan, Christian Gordillo, Hei Ton Chan, Samuel Yamshon, Santiago Thibaud, Markus Mapara, Giorgio Ga Inghirami, Suzanne Lentzsch, Ran Reshef, Adriana Rossi, Samir Parekh, Sundar Jagannath, Shambavi Richard, Ruben Niesvizky, Mark Bustoros
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma. Blood advances 8 (15) (2024)
Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits Van Rhee, Anita D'Souza, Aniko Szabo, Carolina D Schinke, Rajshekhar Chakraborty
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood cancer journal 14 (1) (2024)
Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits Van Rhee, Anita D'Souza, Aniko Szabo, Carolina D Schinke, Rajshekhar Chakraborty
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood cancer journal 14 (1) (2024)
Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits Van Rhee, Anita D'Souza, Aniko Szabo, Carolina D Schinke, Rajshekhar Chakraborty
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood cancer journal 14 (1) (2024)
Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina D Schinke, Anita D Souza, Meera Mohan
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood cancer journal 14 (1) (2024)
Mateo Mejía Saldarriaga, Darren Pan, Caitlin Unkenholz, Tarek H Mouhieddine, Juan Esteban Velez-Hernandez, Katherine Engles, Joshua Alexander Fein, Jorge Monge, Cara Rosenbaum, Roger Pearse, David Jayabalan, Christian Gordillo, Hei Ton Chan, Samuel Yamshon, Santiago Thibaud, Markus Mapara, Giorgio Ga Inghirami, Suzanne Lentzsch, Ran Reshef, Adriana Rossi, Samir Parekh, Sundar Jagannath, Shambavi Richard, Ruben Niesvizky, Mark Bustoros
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma. Blood advances 8 (15) (2024)
Jorge Monge, Meri Razavi, Liming Bao, Sanjay S Patel
Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy. American journal of hematology (2023)